AR051674A1 - Farmacos y profarmacos utiles para el tratamiento de equilibrio energetico en rumiantes - Google Patents
Farmacos y profarmacos utiles para el tratamiento de equilibrio energetico en rumiantesInfo
- Publication number
- AR051674A1 AR051674A1 ARP050104842A ARP050104842A AR051674A1 AR 051674 A1 AR051674 A1 AR 051674A1 AR P050104842 A ARP050104842 A AR P050104842A AR P050104842 A ARP050104842 A AR P050104842A AR 051674 A1 AR051674 A1 AR 051674A1
- Authority
- AR
- Argentina
- Prior art keywords
- ruminants
- compound
- isomer
- energy balance
- negative energy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Nutrition Science (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
El uso de un compuesto de formula (1), un isomero del mismo, un profármaco de dicho compuesto o isomero o una sal farmacéuticamente aceptable de dicho compuesto, isomero o profármaco, en la fabricacion de un medicamento para el tratamiento paliativo, profiláctico o curativo de equilibrio energético negativo en rumiantes. El uso de un compuesto de formula (1), en la fabricacion de un medicamento para el tratamiento paliativo, profiláctico o curativo de la enfermedad de la enfermedad del rumiante asociada con equilibrio energético negativo en rumiantes, en el que, preferiblemente la enfermedad de los rumiantes asociada con equilibrio energético negativo en rumiantes se selecciona de: esteatosis, hepática, distocia, disfuncion inmunitaria, inmunodeficiencia, envenenamiento, cetosis primaria, cetosis secundaria, síndrome de la vaca que no puede sostenerse por sí misma, dispepsia, inapetencia, placenta retenida, abomaso desplazado, mastitis, (endo-)-metritis, esterilidad, baja fertilidad y cojera.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62910904P | 2004-11-18 | 2004-11-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR051674A1 true AR051674A1 (es) | 2007-01-31 |
Family
ID=35695821
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP050104842A AR051674A1 (es) | 2004-11-18 | 2005-11-17 | Farmacos y profarmacos utiles para el tratamiento de equilibrio energetico en rumiantes |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20080096916A1 (es) |
| EP (1) | EP1824484A1 (es) |
| JP (1) | JP2008520643A (es) |
| AR (1) | AR051674A1 (es) |
| AU (1) | AU2005305593A1 (es) |
| CA (1) | CA2587690A1 (es) |
| TW (1) | TW200631579A (es) |
| WO (1) | WO2006054166A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2007210076A1 (en) * | 2006-01-30 | 2007-08-09 | Irm Llc | Polycyclic 1, 2, 3, 4 -tetrahydro- isoquinoline derivatives and compositions comprising them as PPAR modulators |
| US8791105B2 (en) | 2010-07-14 | 2014-07-29 | Kansas State University Research Foundation | Methods for alleviating chronic pain and improving performance of cattle undergoing dehorning or castration |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI52797C (fi) * | 1971-03-17 | 1977-12-12 | Rumen Chemie Ag | Lisärehu märehtijöitä varten. |
| AU779266B2 (en) * | 2000-05-11 | 2005-01-13 | Banyu Pharmaceutical Co., Ltd. | N-acyltetrahydroisoquinoline derivatives |
| US6867224B2 (en) * | 2002-03-07 | 2005-03-15 | Warner-Lambert Company | Compounds that modulate PPAR activity and methods of preparation |
| DE60306636T2 (de) * | 2002-04-09 | 2007-07-05 | Eli Lilly And Co., Indianapolis | Wachstumhormonsekretionsförderer |
| US6987118B2 (en) * | 2003-05-21 | 2006-01-17 | Pfizer Inc. | Tetrahydroisoquinoline derivatives as PPAR-alpha activators |
-
2005
- 2005-11-09 WO PCT/IB2005/003472 patent/WO2006054166A1/en active Application Filing
- 2005-11-09 EP EP05801205A patent/EP1824484A1/en not_active Withdrawn
- 2005-11-09 US US11/575,431 patent/US20080096916A1/en not_active Abandoned
- 2005-11-09 CA CA002587690A patent/CA2587690A1/en not_active Abandoned
- 2005-11-09 AU AU2005305593A patent/AU2005305593A1/en not_active Abandoned
- 2005-11-09 JP JP2007542154A patent/JP2008520643A/ja active Pending
- 2005-11-15 TW TW094140124A patent/TW200631579A/zh unknown
- 2005-11-17 AR ARP050104842A patent/AR051674A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006054166A1 (en) | 2006-05-26 |
| EP1824484A1 (en) | 2007-08-29 |
| AU2005305593A1 (en) | 2006-05-26 |
| US20080096916A1 (en) | 2008-04-24 |
| CA2587690A1 (en) | 2006-05-26 |
| JP2008520643A (ja) | 2008-06-19 |
| TW200631579A (en) | 2006-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO6331425A2 (es) | Composiciones que comprenden n-(3,4-difluoro-2-(2-fluoro-4-yodofenilamino)6-metoxifenil)-1-(2,3-dihidroxiproxipropil)ciclopropan-1-sulfamida | |
| CO2020001860A2 (es) | Derivados de 3-(1-oxoisoindolin-2-il)piperidina-2,6-diona y usos de los mismos | |
| BRPI0511481A (pt) | uso | |
| ES2522567T3 (es) | Composición farmacéutica que comprende amlodipino y losartán | |
| AR067347A1 (es) | Combinacion antihelmintica | |
| GT200000041A (es) | Uso de inhibidores de cyp2d6 en terapias de combinacion. | |
| CR7654A (es) | Una combinacion de azelatina y esteroides | |
| AR069552A1 (es) | Formulaciones para el tratamiento de semillas y metodos de uso | |
| AR048588A1 (es) | Uso de inhibidores de la fosfodiesterasa de tipo iii (pde iii) para la reduccion del tamano del corazon en mamiferos que padecen insuficiencia cardiaca | |
| CL2008001297A1 (es) | N-[(1s)-1-(5-fluoropirim idin-2-i1 )etil]-3-(5-isopropoxi-1 h-pirazol-3-il )-3h-imidazo[4,5-b]piridin-5amina o una sal farmacéuticamente aceptabie del mismo; composición farmacéutica que lo comprende; y su uso en el tratamiento del cáncer. | |
| AR080721A1 (es) | 1-((3-ciano-piridin-2-il) metil]-3-metil-7-(2-butin-1-il)-8- (3-(r)- amino-piperidin-1-il)- xantina para tratamiento de un trastorno metabolico de un animal no humano predominantemente carnivoro | |
| AR010634A1 (es) | Composicion farmaceutica en forma de una solucion para la administracion de inhibidores de proteasa hiv | |
| AR051968A1 (es) | Metodos y composiciones que utilizan inhibidores de jnk para el tratamiento y manejo de la lesion del sistema nervioso central | |
| AR018862A1 (es) | Formulacion farmaceutica de liberacion prolongada, mejorada para la administracion oral de nefazodona o una sal farmaceuticamente aceptable de la misma;forma de dosificacion oral que la comprende y uso de dicha formulacion para preparar dicha forma de dosificacion | |
| AR027153A1 (es) | Sistema multitableta de oxibutinina para el tratamiento de la incontinencia | |
| CL2019001256A1 (es) | Tratamiento de enfermedades del sistema nervioso central (snc) con estimulantes de sgc. | |
| CL2022002303A1 (es) | Medicamentos en aerosol | |
| MX2021008010A (es) | Composiciones y métodos para tratar las enfermedades del hígado graso no alcohólico (nafld). | |
| AR117600A1 (es) | Formulaciones de un inhibidor de axl / mer | |
| AR119159A1 (es) | Tratamientos de angioedema | |
| AR051674A1 (es) | Farmacos y profarmacos utiles para el tratamiento de equilibrio energetico en rumiantes | |
| AR054729A1 (es) | Sistema de administracion | |
| AR056517A1 (es) | Composiciones y metodos farmaceuticos utilizando temozolomida y un inhibidor de la proteina quinasa | |
| CO5550418A2 (es) | Formulaciones antihistaminicas para formas de dosificacion de capsula blanda | |
| ECSP088285A (es) | 3-(2-dimetilaminometil ciclohexil) fenol formulación retardada. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |